PLRX vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

PLRX

47.9
AI Score
VS
CLYM Wins

CLYM

50.9
AI Score

Investment Advisor Scores

PLRX

48score
Recommendation
HOLD

CLYM

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PLRX CLYM Winner
Net Income 149.30M -27.22M PLRX
Operating Income -156.37M -30.57M CLYM
ROE 82.4% -11.4% PLRX
ROA 66.3% -11.1% PLRX
Total Assets 225.23M 246.29M CLYM
Cash 45.45M 44.11M PLRX
Current Ratio 12.00 31.45 CLYM
Free Cash Flow -128.71M -25.18M CLYM

Relative Price Performance (Last 90 Days)

PLRX 1M: +9.3% · 3M: +2.6% CLYM 1M: -1.0% · 3M: +30.6%

Current Technical Phase

PLRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 56.6 · Price: $1.17

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $14.25

Fundamentals Snapshot

Metric PLRX CLYM
Market Cap
Forward P/E -0.9 -14.2
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -1.48 -0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.